This session will open with an overview of Vision 2030 and explanation of the Kingdom’s commitment to the role of biotech in advancing healthcare. A panel discussion will then explore the key drivers of biotechnology advancement in Saudi Arabia and the opportunities for international partners. Leaders in healthcare, regulation, and investment will discuss how a synergistic approach to clinical trials, regulatory frameworks, and strategic partnerships can propel the Kingdom to the forefront of biotechnology innovation.